Breaking News, Promotions & Moves

Metrion Biosciences Appoints Lee Patterson as CEO

Patterson will guide the company as it seeks to execute a growth strategy, enhancing its specialist services and expanding further in key global markets.

Author Image

By: Charlie Sternberg

Associate Editor

Metrion Biosciences, a specialist preclinical contract research organization (CRO) and a leader in ion channel screening, has appointed Lee Patterson as its new CEO, effective December 2, 2024.   An experienced life sciences and CRO executive, Patterson will guide the company as it seeks to execute an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets. He succeeds Dr. Andrew Southan, who has decided to step down as CEO after five years in t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters